BAUSCH HEALTH COS INC (BHC.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:BHC - CA0717341071 - Common Stock
BHC.CA Key Statistics, Chart & Performance
The current stock price of BHC.CA is 10.21 CAD. In the past month the price increased by 3.65%. In the past year, price decreased by -10.24%.
BHC.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.52B | ||
| CRON.CA | CRONOS GROUP INC | 24.67 | 1.42B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 6.91 | 856.96M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 4.96 | 615.03M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 607.96M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 581.84M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 588.48M | ||
| TSND.CA | TERRASCEND CORP | N/A | 379.30M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 16.33 | 372.94M | ||
| HITI.CA | HIGH TIDE INC | N/A | 333.30M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 331.14M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 314.33M |
Related stock screener links
About BHC.CA
Company Profile
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 20,700 full-time employees. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Company Info
BAUSCH HEALTH COS INC
2150 St. Elzear Blvd. West
Laval QUEBEC H7L 4A8 CA
CEO: Joseph C. Papa
Employees: 20700
Phone: 18003611448
BAUSCH HEALTH COS INC / BHC.CA FAQ
What does BAUSCH HEALTH COS INC do?
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. The company is headquartered in Laval, Quebec and currently employs 20,700 full-time employees. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Can you provide the latest stock price for BAUSCH HEALTH COS INC?
The current stock price of BHC.CA is 10.21 CAD. The price increased by 2.92% in the last trading session.
What is the dividend status of BAUSCH HEALTH COS INC?
BHC.CA does not pay a dividend.
How is the ChartMill rating for BAUSCH HEALTH COS INC?
BHC.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is BHC.CA stock listed?
BHC.CA stock is listed on the Toronto Stock Exchange exchange.
What sector and industry does BAUSCH HEALTH COS INC belong to?
BAUSCH HEALTH COS INC (BHC.CA) operates in the Health Care sector and the Pharmaceuticals industry.
BHC.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to BHC.CA. When comparing the yearly performance of all stocks, BHC.CA turns out to be only a medium performer in the overall market: it outperformed 42.31% of all stocks.
BHC.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to BHC.CA. There are concerns on the financial health of BHC.CA while its profitability can be described as average.
BHC.CA Financial Highlights
Over the last trailing twelve months BHC.CA reported a non-GAAP Earnings per Share(EPS) of 5.23. The EPS increased by 1.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.61% | ||
| ROA | 1.35% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
BHC.CA Forecast & Estimates
9 analysts have analysed BHC.CA and the average price target is 10.2 CAD. This implies a price decrease of -0.1% is expected in the next year compared to the current price of 10.21.
For the next year, analysts expect an EPS growth of 5.32% and a revenue growth 6.13% for BHC.CA